Patent expiry and biosimilars: difference between revisions
Diff·revision 23 → 24·15:15, 7 Feb 2026
Difference between revision 23 and revision 24 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 23 — 17:48, 6 Jan 2026 PreregPriya (talk) add the customs-detention point with its source 4,553 bytes ±0 | Revision 24 — 15:15, 7 Feb 2026 Peptide_Pete (talk) add the cross-link to the legal-status-by-jurisdiction list 4,553 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |